Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Beckman Coulter Acquires Siemens Healthcare Diagnostics’ Clinical Microbiology Business

By Labmedica International staff writers
Posted on 24 Jul 2014
Print article
Beckman Coulter (Brea, CA, USA), an indirect wholly-owned subsidiary of Danaher Corp. (Washington DC, MD, USA) has entered into a definitive agreement to purchase the clinical microbiology business of Siemens Healthcare Diagnostics (Chicago, IL, USA). The transaction is expected to close in the first quarter of 2015. The agreement is subject to applicable regulatory approvals and other customary closing conditions.

The Siemens clinical microbiology business is a leader in microbial identification and antibiotic sensitivity testing (ID/AST). The business operates with a base of over 6,000 instruments globally. The microbiology product line includes the MicroScanInstruments and MicroScan panels/consumables, along with data management solutions. The MicroScan systems are known for accuracy and detection of emerging resistance.

Beckman Coulter diagnostics president Arndt Kaldowski said, "The clinical microbiology business will be an excellent complement to Beckman Coulter's Diagnostics business with a strong reputation and market position. Adding its ID/AST solutions to our existing products and services will create an opportunity to enhance our offerings to laboratory customers and improve patient care. The acquisition expands our product portfolio with differentiated analytical systems and menu that elevate our clinical capabilities for customers, while driving continued growth."

Beckman Coulter Diagnostics develops clinical diagnostic products that help advance and optimize the clinical laboratory. The company is dedicated to providing solutions to laboratories of all sizes––offering a broad portfolio of chemistry, immunoassay, hematology, urinalysis, automation, and information systems. For further information about the company see www.beckman-coulter.com.

Related Links:

Beckman Coulter

Danaher Corp.

Siemens Healthcare Diagnostics



Print article
Abbott Diagnostics

Channels

Lab Tech.

view channel
Image: The nano-DLD chip (2 cm x 2 cm) mounted in a microfluidic jig. The technology allows a liquid sample to be passed, in continuous flow, through a silicon chip containing an asymmetric pillar array that allows sorting a microscopic waterfall of nanoparticles, separating particles by size down to 20 nanometer resolution (Photo courtesy of IBM Research).

Lab-on-a-Chip Technology Breaks New Bioparticle Separation Record

Scientists have developed a new lab-on-a-chip technology that can, for the first time, separate biological particles at the nanoscale down to 20 nanometers in diameter, a scale that gives access to important... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.